M.D. Hamid Nasri
Shahrekord University of Medical Sciences, Hajar Medical,
Educational and Therapeutic Center, Hemodialysis Section, Shahrekord, Iran
M.D. Shahin Shirani
Cardiovacular Research Center, Isfahan University of Medical Sciences, Khorram St. Isfahan, Iran
M.D. Azar Baradaran
Department of Biochemistry, Center of Research and Reference Laboratory of Iran,
Hospital Bu Ali, Damavand st., 17117, P.O. Box 17115-365, Tehran, Iran
ABSTRACT
To consider the prevalence of pulmonary artery pressure in End-stage Renal Disease (ESRD) patients, a study was conducted on maintenance of hemodialysis patients and a group of normal subjects. For assessment of pulmonary artery pressure all participants were subjected to two-dimensional and doppler echocardiographic studies that for patients were done after their hemodialysis session. In this study a significant difference of Pulmonary Artery Systolic Pressure (PASP) between patients and normal subjects with more values in hemodialysis patients was seen. A significant positive correlation of pulmonary artery pressure with age of control group and also significant positive correlation of pulmonary artery pressure with age of hemodialysis group were found. A significant positive correlation of PASP with duration and dosages of hemodialysis treatment were seen too. A high prevalence of pulmonary hypertension in hemodialysis needs more attention to this aspect of hemodialysis patients because pulmonary hypertension is a disease with poor prognosis.
PDF References Citation
How to cite this article
M.D. Hamid Nasri, M.D. Shahin Shirani and M.D. Azar Baradaran, 2006. Pulmonary Artery Pressure in Maintenance Hemodialysis Patients. Pakistan Journal of Biological Sciences, 9: 107-110.
DOI: 10.3923/pjbs.2006.107.110
URL: https://scialert.net/abstract/?doi=pjbs.2006.107.110
DOI: 10.3923/pjbs.2006.107.110
URL: https://scialert.net/abstract/?doi=pjbs.2006.107.110
REFERENCES
- Yao, Q., R.P. Filho, B. Lindholm and P. Stenvinkel, 2004. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J. Urol. Nephrol., 38: 405-416.
PubMed - Urso, S., M. Garozzo, F. Milone and G. Battaglia, 2004. Cardiovascular risk markers in hemodialysis patients. Int. J. Artif Organs, 27: 1083-1090.
Direct Link - Nasri, H., A. Baradaran and A.S.A. Naderi, 2004. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Acta Med. Aust., 3: 67-72.
PubMedDirect Link - Yigla, M., F. Nakhoul, A. Sabag, N. Tov, B. Gorevich, Z. Abassi and S.A. Reisner, 2003. Pulmonary hypertension in patients with end-stage renal disease. Chest, 123: 1577-1582.
CrossRef - Marangoni, S., A. Quadri, A. Dotti, S. Scalvini and M. Volterrani et al., 1988. Noninvasive assessment of pulmonary hypertension: A simultaneous echo-Doppler hemodynamic study. Cardiology, 75: 401-408.
Direct Link - Amin, M., A. Fawzy, M.A. Hamid and A. Elhendy, 2003. Pulmonary hypertension in patients with chronic renal failure role of parathyroid hormone and pulmonary artery calcifications. Chest, 124: 2093-2097.
CrossRef